Sore Arm; fatigue; fever; chills; body aches; nausea; large red swollen area right below injection spot; The swollen area is hard, red, warm and itchy; The swollen area is hard, red, warm and itchy; Booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 14Nov2021 14:30 (Lot number: FF2590) at the age of 48 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Penicillin Allergy" (unspecified if ongoing); "Hashimoto" (unspecified if ongoing); "depression" (unspecified if ongoing); "anxiety" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE SODIUM; VITRON-C; BUPROPION HCL; LAMOTRIGINE. Vaccination history included: Bnt162b2 (Prev dose brand=Pfizer, Prev dose lot number=ER8727, Prev dose administration time=04:30 PM, Prev dose dose number=1), administration date: 18Mar2021, when the patient was 47 years old, for COVID-19 immunization, reaction(s): "Sore Arm"; Bnt162b2 (prev dose brand=Pfizer, prev dose lot number=ER8729, prev dose administration time=04:30 PM, prev dose number=2, prev dose vaccine location=Left arm), administration date: 08Apr2021, when the patient was 47 years old, for COVID-19 immunization, reaction(s): "Sore Arm", "fever", "chills", "body aches"; Bnt162b2 (Prev dose brand=Pfizer, Prev dose lot number=ER8729, Prev dose administration time=04:30 PM , Prev dose dose number=2), administration date: 08Apr2021, when the patient was 47 years old, for COVID-19 Immunization, reaction(s): "fatigue"; Flu (Other vaccine 4weeks product=Flu, Other vaccine 4weeks vaccine location=Left Arm), administration date: 29Oct2021. The following information was reported: IMMUNISATION (non-serious) with onset 14Nov2021, outcome "unknown", described as "Booster"; PAIN IN EXTREMITY (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "Sore Arm"; FATIGUE (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "fatigue"; PYREXIA (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "fever"; CHILLS (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "chills"; PAIN (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "body aches"; NAUSEA (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "nausea"; PERIPHERAL SWELLING (non-serious) with onset 14Nov2021 02:00, outcome "recovering", described as "large red swollen area right below injection spot"; ERYTHEMA (non-serious), PRURITUS (non-serious) all with onset 14Nov2021 02:00, outcome "recovering" and all described as "The swollen area is hard, red, warm and itchy". Therapeutic measures were not taken as a result of pain in extremity, fatigue, pyrexia, chills, pain, nausea, peripheral swelling, erythema, pruritus.  Additional information: Patient was not tested with COVID-19 Prior to vaccination. Patient did not test for COVID-19 post the vaccination.  Follow-Up (23Nov2021): Follow-up attempts are completed. No further information is expected.